CompareSupplements

What it usually meansvsWhat to look at next

VLDL and LDL are two stages of the same particle. Here is how one becomes the other, why your report calculates VLDL from triglycerides, and how apoB settles which one matters for you.

The short answer

VLDL is the particle your liver uses to ship triglyceride; once it unloads that fat it becomes LDL, a smaller, cholesterol-rich particle that causes most artery plaque. LDL is the number guidelines treat. The VLDL cholesterol line on a standard report is triglycerides divided by 5, so a high VLDL flags high triglycerides, often from insulin resistance or liver fat. Both carry one apoB protein each, so an apoB test counts them together and is the fairest way to judge combined risk.

Ask AI about this pageChatGPTClaudePerplexity
SupplementWhat it usually meansNot one we carry. The comparison below covers it in full.
SupplementWhat to look at nextNot one we carry. The comparison below covers it in full.

Side by side

What it usually meansWhat to look at next
High LDL, normal VLDLGenes or diet; LDL tells most of the story. LDL of 190 mg/dL (4.9 mmol/L) or more suggests an inherited cause.Family history, Lp(a) once in life, a clinician review
Normal LDL, high VLDLInsulin resistance, liver fat or alcohol. LDL cholesterol undercounts the particles.ApoB or non-HDL, fasting insulin, HbA1c, TG/HDL ratio
Both highCombined high cholesterol; also check for underactive thyroid, kidney disease or a medicine effectThyroid and kidney results, apoB, a clinician review
Both normalReassuring for nowLp(a) once in life, then repeat on your usual schedule

The differences that matter

  1. 01
    Count the particles, not the cargo

    VLDL and LDL each carry one apoB protein. LDL particles are about 9 in 10 of them, remnants of VLDL are fewer but more harmful each, and heart benefit tracks the fall in apoB. Lowering triglycerides without lowering apoB did not prevent heart events in PROMINENT.

  2. 02
    VLDL on your report is triglycerides divided by 5

    VLDL cholesterol (calc) is an estimate from the Friedewald formula, so it carries the same information as your triglyceride line and stops working at triglycerides of 400 mg/dL.

VLDL and LDL are two stages of one particle. Your liver sends out VLDL packed with triglyceride, your muscles and fat tissue strip most of that triglyceride off within hours, and the leftover particle, smaller and richer in cholesterol, is LDL. That shared history is why a lipid report prints both lines and why they often rise together.

LDL is the target, VLDL is the clue

LDL cholesterol✓ The treatment target
Low-density lipoprotein
Made byVLDL, after it unloads its triglyceride
Main cargoCholesterol, about half the particle
Size18 to 25 nm
How your report gets itCalculated from the panel, sometimes measured directly
Desirable levelUnder 100 mg/dL (2.6 mmol/L)
What moves it mostGenes, saturated fat, statins
How fast it movesWeeks; rechecked 4 to 12 weeks after a statin change
Best atPredicting and tracking plaque risk
VLDL cholesterolContext: triglycerides and metabolism
Very-low-density lipoprotein
Made byThe liver
Main cargoTriglyceride, about half or more
Size30 to 80 nm
How your report gets itTriglycerides divided by 5 (mg/dL) or 2.2 (mmol/L)
Desirable levelUnder 30 mg/dL (0.78 mmol/L)
What moves it mostAdded sugar, alcohol, excess calories, liver fat
How fast it movesDays to a few weeks
Best atFlagging high triglycerides and insulin resistance
Particle sizes from Endotext 1; statin recheck window from the 2018 AHA/ACC cholesterol guideline 2; the LDL and VLDL limits are the common US lab reference limits.

What VLDL and LDL are

Fat does not dissolve in blood, so the body ships it in lipoproteins: shells of protein and phospholipid wrapped around a core of triglyceride and cholesterol. VLDL (very-low-density lipoprotein) is made in the liver and carries mostly triglyceride, the fat your body burns for fuel or stores. LDL (low-density lipoprotein) is what VLDL becomes after delivering that triglyceride, and it carries mostly cholesterol 1. In one line for anyone asking what VLDL cholesterol is: it is the cholesterol riding inside the liver's triglyceride carriers, and most labs estimate it rather than measure it.

The detail that ties the two together is a protein called apolipoprotein B-100 (apoB). Every VLDL, every remnant and every LDL particle carries exactly one apoB molecule, and keeps it for life 4. That makes VLDL and LDL the same family of artery-entering particles, and it means a single apoB test counts all of them. HDL carries a different protein and works in the opposite direction, which the HDL vs LDL page covers.

ParticleSizeMain cargoMade whereApoB per particle
VLDL30 to 80 nmTriglycerideLiverOne apoB-100
IDL (remnant)25 to 35 nmTriglyceride and cholesterolFrom VLDL, in the bloodOne apoB-100
LDL18 to 25 nmCholesterolFrom IDL, in the bloodOne apoB-100
HDL5 to 12 nmCholesterol and proteinLiver and gutNone (carries apoA-I)
Chylomicron75 to 1,200 nmTriglyceride from foodGutOne apoB-48, a shorter form

How VLDL turns into LDL

From triglyceride carrier to cholesterol carrier

1
The liver packs VLDL
The liver bundles triglyceride, some cholesterol and one apoB-100 into a large VLDL particle and releases it into the blood.
2
Lipoprotein lipase unloads it
Lipoprotein lipase, an enzyme on the walls of small blood vessels in muscle and fat, pulls triglyceride out for fuel or storage. VLDL triglyceride turns over within hours 1.
3
A remnant forms
The shrunken particle, called IDL or a remnant, has lost much of its triglyceride. The liver takes some remnants back; hepatic lipase trims the rest.
4
The same particle, now LDL
What is left is LDL: the same apoB-100, now mostly cholesterol. LDL stays in the blood for about 2 to 3 days, far longer than VLDL, so it builds up 1.
5
High VLDL makes LDL smaller
When triglyceride-rich VLDL is plentiful, a transfer protein (CETP) swaps triglyceride into LDL and cholesterol out; lipases then trim LDL into smaller, denser particles. The same cholesterol spreads across more particles.
Based on Feingold, Endotext 1. Step 5 is why high triglycerides go with small dense LDL.

Step 5 answers the small dense LDL question. Small dense LDL is mostly a downstream effect of too much VLDL: when the liver overproduces triglyceride-rich particles, the LDL that comes out of them is smaller and more numerous. Two people with the same LDL cholesterol can carry very different numbers of LDL particles for this reason, and the person with high triglycerides usually carries more.

Why your report says VLDL cholesterol (calc)

Almost no routine lab measures VLDL cholesterol. The "calc" means it was estimated with the Friedewald formula from 1972, which assumes VLDL holds one part cholesterol for every five parts triglyceride: VLDL cholesterol equals triglycerides divided by 5 in mg/dL, or divided by 2.2 in mmol/L. The lab then subtracts that estimate and HDL from total cholesterol to get LDL. Because VLDL cholesterol is triglycerides divided by a fixed number, the VLDL line on a report rises and falls in lockstep with the triglycerides line and adds no new information.

The fixed factor of 5 fails at the edges. The Friedewald formula is not used when triglycerides reach 400 mg/dL (4.5 mmol/L), and it underestimates LDL when LDL is low and triglycerides are high. Martin and colleagues at Johns Hopkins (JAMA, 2013) replaced the 5 with a sliding factor drawn from 174 strata of real patients, and the 2018 AHA/ACC guideline calls the Martin-Hopkins estimate reasonable when LDL is below 70 mg/dL 2. A 2020 NIH equation (Sampson) does a similar job. Many UK and European reports skip the VLDL line and print non-HDL cholesterol instead, which already includes VLDL. Readers with mmol/L results can switch units with the cholesterol units converter.

MarkerDesirableBorderlineHighVery high
VLDL cholesterol (calc)Under 30 mg/dL (0.78 mmol/L)No guideline bandOver 30 mg/dLFollows triglycerides
TriglyceridesUnder 150 mg/dL (1.7 mmol/L)150 to 199 (1.7 to 2.2)200 to 499 (2.3 to 5.6)500 or more (5.6 or more)
LDL cholesterolUnder 100 mg/dL (2.6 mmol/L); 100 to 129 near optimal130 to 159 (3.4 to 4.1)160 to 189 (4.1 to 4.9)190 or more (4.9 or more)

An example VLDL cholesterol of 34 mg/dLmg/dL

34 mg/dLa little high · same as 0.88 mmol/L; it implies triglycerides of about 170 mg/dL
Desirable0–30Above range30–60
A VLDL cholesterol of 34 mg/dL means triglycerides are mildly raised. Read it with LDL and apoB, and go over the pattern with your clinician.
Illustrative reader value. The 30 mg/dL limit is the common US lab reference; triglyceride categories from the AHA statement on triglycerides 8.

Read the three rows of that table as one story. A VLDL cholesterol of 40 mg/dL is the same fact as triglycerides of 200 mg/dL, said a second way, and the triglyceride categories carry the guideline meaning. If your report also gives an LDL marked "calc" and your triglycerides are above about 150 mg/dL, the Friedewald LDL may be a few points low, which is one more reason to look at non-HDL or apoB. The full walk-through of every line is in how to read your lipid panel.

CalculatorLDL calculatorGot total cholesterol, HDL and triglycerides? Recalculate LDL with the newer equation, which handles high triglycerides better.Work it out

Which is worse, VLDL or LDL?

LDL does more damage across a population, because there is so much more of it. LDL is a proven cause of plaque: genetic studies, cohort studies and drug trials all point the same way, and in statin trials each 1 mmol/L (39 mg/dL) fall in LDL cholesterol cut major vascular events by about 22% 2. LDL particles also make up the large majority of apoB particles in the blood 4.

About 90%of apoB particles in a typical blood sample are LDLSniderman et al., JAMA Cardiology 2019 4

Particle for particle, the remnants left over from VLDL are at least as harmful. Each remnant carries more cholesterol than an LDL particle, and in a Copenhagen genetic study a 1 mmol/L (39 mg/dL) higher non-fasting remnant cholesterol was linked to a 2.8-fold higher causal risk of heart disease 5. Size matters here. The largest VLDL particles are mostly too big to slip through the artery lining, while smaller VLDL and remnants get in and stay 5.

The tie-breaker is particle count. Ference and colleagues compared people born with gene variants that lower triglycerides against people born with variants that lower LDL, and found the heart benefit was the same per unit fall in apoB 6. The PROMINENT trial then tested the other side: pemafibrate, a fibrate-type drug, cut triglycerides by about 26% in people with type 2 diabetes, apoB did not fall, and heart attacks and strokes did not fall either 7. Lowering the triglyceride cargo without lowering the number of particles did not help.

The clinical benefit of lowering triglyceride and LDL-C levels may be proportional to the absolute change in ApoB.

Ference BA et al., JAMA 2019 6

So the useful answer to "which is worse" is to count the particles, not the cargo. The ApoB vs LDL page explains when the two disagree. If apoB is not on your report, non-HDL cholesterol (total cholesterol minus HDL) is the free stand-in, and the 2019 ESC/EAS guidelines name both as secondary targets in people with high triglycerides or diabetes.

Reading both numbers together: four patterns

The second row is the one people miss. In insulin resistance the liver overproduces large VLDL in proportion to its fat content, a pattern Adiels and colleagues traced to liver fat in 2006, and that VLDL turns into extra small dense LDL. LDL cholesterol can read a comfortable 100 mg/dL while apoB sits high. Insulin resistance explains the rest of that picture. Whatever the pattern, lipoprotein(a) is worth reading once, because it is mostly inherited and neither VLDL nor LDL reveals it.

The first row has its own trap. An LDL of 160 mg/dL in someone with normal triglycerides is a cleaner signal than the same LDL with triglycerides of 300 mg/dL, because the second report hides extra particles behind a calculated number. If you have both LDL cholesterol and apoB from the same draw, the tool below shows whether they agree. When they disagree, apoB is the better guide to particle count 4, and the gap itself is worth showing your clinician.

Interactive

Do your apoB and LDL agree?

Enter both numbers to see whether your particle count and your cholesterol tell the same story. Nothing leaves your browser.

Enter both your LDL-C and apoB to compare them.
Have your own numbers?Have your results? Read them free.Drop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.Read my results

What raises each one

The causes overlap, but each number has its own main drivers 1. Two short lists make the split clear.

Mostly raises VLDL and triglycerides

  • Excess calories, added sugar and refined starch, especially fructose
  • Alcohol, even moderate amounts in some people
  • Liver fat, insulin resistance and poorly controlled diabetes
  • Underactive thyroid and chronic kidney disease
  • Some medicines: oral estrogen, steroids, some diuretics and beta-blockers, retinoids
  • Inherited high triglycerides

Mostly raises LDL

  • Saturated and trans fat in the diet
  • Inherited conditions such as familial hypercholesterolemia
  • Underactive thyroid
  • Menopause, as estrogen falls
  • Nephrotic syndrome (heavy protein loss in urine) and some medicines

Saturated fat sits on the LDL list for a reason. Its main effect is to slow the liver's LDL receptors, the doors that pull LDL out of the blood, so LDL lingers; its effect on VLDL output is small. Sugar and alcohol work the other way: the liver turns the surplus into triglyceride and ships it out as VLDL. Underactive thyroid appears on both lists because thyroid hormone keeps LDL receptors busy and helps clear triglyceride, which is why a new rise in both numbers often prompts a thyroid check.

What lowers each one, and how fast

VLDL and triglycerides answer to calories, sugar and alcohol, and they move fast, because VLDL lives for hours. LDL answers to fat quality, fibre, genes and medicine, and moves over weeks, because each LDL particle lives for days. The AHA's statement on triglycerides puts the size of the lifestyle effect plainly: losing 5 to 10% of body weight lowers triglycerides by about 20%, and cutting added sugar and alcohol while adding aerobic exercise can lower them by 20 to 50% 8. Retest timing follows the same logic. Triglycerides reflect the last few weeks, while the 2018 AHA/ACC guideline rechecks LDL 4 to 12 weeks after a statin is started or changed 2.

LeverEffect on VLDL and triglyceridesEffect on LDLWhen it shows
Losing 5 to 10% of body weightDown about 20% 8Small fallWeeks to months
Cutting added sugar, refined starch and alcoholDown, often sharply when high 8Little changeDays to weeks
Regular aerobic exerciseDownLittle changeWeeks
Swapping saturated fat for unsaturated fatLittle changeDownWeeks
Soluble fibre (oats, beans)Little changeDown modestlyWeeks
StatinsDown modestlyDown 30 to 49% (moderate) or 50% or more (high intensity) 2Rechecked at 4 to 12 weeks 2
Fibrates or prescription omega-3DownLittle change, sometimes up 7Weeks

The last row carries the PROMINENT lesson again: a drop in triglycerides is good to see, and the event benefit tracks apoB 6. Food changes that move LDL are laid out in foods that lower cholesterol, and the cholesterol ratio calculator turns triglycerides and HDL into a TG/HDL ratio, a rough read on insulin resistance. Any medicine decision belongs with your clinician, who weighs your full risk.

When to see a doctor

Below those lines, a high VLDL or LDL is a conversation to have at your next visit, with your full panel and family history in hand. High cholesterol covers how clinicians weigh it. A low VLDL cholesterol is usually good news, since it means low triglycerides. Very low triglycerides and very low cholesterol together are uncommon and can point to poor fat absorption, an overactive thyroid or a rare inherited low-apoB condition, which is worth raising with a clinician if it shows up on more than one report.

Free, no accountRead your blood testGot a lipid panel with VLDL, LDL and triglycerides on it? Read every line together, free.Read my results

Questions

Is VLDL worse than LDL?

Per particle, VLDL remnants carry more cholesterol and are at least as harmful as LDL. LDL causes more disease overall because LDL particles make up about 90% of the apoB particles in blood. An apoB test counts both, and heart benefit tracks the fall in apoB.

Can LDL be normal and VLDL high?

Yes. Normal LDL with high VLDL is a common pattern in insulin resistance, liver fat and regular alcohol use. In that pattern LDL cholesterol undercounts the particles in the blood, so apoB or non-HDL cholesterol gives a truer read.

Is VLDL the same as triglycerides?

VLDL is the particle that carries most of the triglyceride in fasting blood. The VLDL cholesterol line on most reports is calculated as triglycerides divided by 5 in mg/dL (or 2.2 in mmol/L), so the two lines always move together.

Do statins lower VLDL?

Statins lower VLDL and triglycerides modestly and lower LDL a lot: about 30 to 49% at moderate intensity and 50% or more at high intensity, per the 2018 AHA/ACC guideline. Whether a statin fits your situation is a decision for you and your clinician.

Do I need to fast for a VLDL result?

Usually no. After normal meals triglycerides rise by about 26 mg/dL on average, so a non-fasting VLDL cholesterol reads about 5 mg/dL higher. US and European guidance accept non-fasting panels for routine checks; a clinician may ask for a fasting repeat if triglycerides come back high.

Citations
  1. Feingold KR. Introduction to Lipids and Lipoproteins. Endotext (NCBI Bookshelf), 2024
  2. Grundy SM et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation 2019;139:e1082-e1143
  3. Nordestgaard BG et al. Fasting is not routinely required for determination of a lipid profile. EAS/EFLM consensus. Eur Heart J 2016;37:1944-1958
  4. Sniderman AD et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol 2019;4:1287-1295
  5. Varbo A et al. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013;61:427-436
  6. Ference BA et al. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA 2019;321:364-373
  7. Das Pradhan A et al. Triglyceride lowering with pemafibrate to reduce cardiovascular risk (PROMINENT). N Engl J Med 2022;387:1923-1934
  8. Miller M et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123:2292-2333

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.